Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration
- PMID: 3307712
- DOI: 10.1001/archneur.1987.00520200037015
Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration
Abstract
Two patients with paraneoplastic cerebellar degeneration with anti-Purkinje cell antibodies are described. Using an avidin-biotin peroxidase complex method, serum anti-Purkinje cell antibody titers of these patients were 1:32,000 and 1:64,000, and the cerebrospinal fluid titers were 1:40 and 1:320, respectively. After extensive plasmapheresis together with radiation therapy and chemotherapy, the cerebellar symptoms of one patient ameliorated concomitantly with a reduced serum anti-Purkinje cell antibody titer. Four B-cell lines producing anti-Purkinje cell antibodies were established from one patient by Epstein-Barr virus transformation of peripheral lymphocytes. None of these antibodies reacted with peripheral T cells, although the serum anti-Purkinje cell activity of the patient was markedly reduced after absorption with purified human T cells. Thus, anti-Purkinje cell antibodies are apparently directed both to antigens unique to the cerebellar tissue and those shared by T cells.
Similar articles
-
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.Clin Neurol Neurosurg. 1995 Feb;97(1):101-5. doi: 10.1016/0303-8467(95)00006-6. Clin Neurol Neurosurg. 1995. PMID: 7788964
-
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.Clin Neurol Neurosurg. 1995 Feb;97(1):95-100. doi: 10.1016/0303-8467(95)00005-5. Clin Neurol Neurosurg. 1995. PMID: 7788981
-
Ovarian carcinoma and paraneoplastic cerebellar degeneration.Obstet Gynecol. 1988 Dec;72(6):922-5. doi: 10.1097/00006250-198812000-00023. Obstet Gynecol. 1988. PMID: 3186102
-
A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.Neurology. 1988 Jul;38(7):1018-26. doi: 10.1212/wnl.38.7.1018. Neurology. 1988. PMID: 3290700 Review.
-
[Paraneoplastic cerebellar degeneration].Nihon Rinsho. 1994 Nov;52(11):3000-5. Nihon Rinsho. 1994. PMID: 7996701 Review. Japanese.
Cited by
-
Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon.J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):713-6. doi: 10.1136/jnnp.56.6.713. J Neurol Neurosurg Psychiatry. 1993. PMID: 8509793 Free PMC article.
-
Paraneoplastic syndromes: a role for the immune system.J Neurol. 1989 Jan;236(1):1-3. doi: 10.1007/BF00314208. J Neurol. 1989. PMID: 2644394 Review. No abstract available.
-
Purkinje cell antibodies in a patient with cerebellar disorder: detection of responsible antigenic proteins.J Neurol. 1991 Aug;238(5):288-92. doi: 10.1007/BF00319741. J Neurol. 1991. PMID: 1824552
-
Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells.Acta Neuropathol. 1993;86(2):206-11. doi: 10.1007/BF00334892. Acta Neuropathol. 1993. PMID: 8213077
-
A review of the therapy of paraneoplastic neurologic syndromes.J Neurooncol. 1999 Jan;41(2):181-94. doi: 10.1023/a:1006133102928. J Neurooncol. 1999. PMID: 10222439
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical